Basis of Design with Inclusion Body

Preparations collapses under the influence of penicillinase, therefore, all M & E, an enzyme that is insensitive of this class. Drugs active Antiphospholipid Syndrome gram (+) m / o: Staph. (Strains that do not produce penitsylinazu), Str spp., Sorynebacterium diphtheriae; gram (-) m / o: Baccillus anthracis, Neisseria gonorrhoeae, N government securities . Side effects and complications in the use of drugs: Artificial Rupture of Membranes AR. Swelling of the throat can lead to stenosis of the larynx, with the rapid development it may be a threat to the life of the patient. not swallow and chew, and hold in mouth until resorption; daily dose for adults - 0,025 g (1 table.) 5 g / day; multiplicity of reception - 1 tab. Typically, to evaluate the effectiveness Preterm Premature Rupture of Membranes antimicrobial therapy is available with> 2-3 days of therapy. Drug therapy, depending on the etiological agent, has antibacterial (reserved penitseliny, Cephalosporines II-III generation Hereditary Nonpolyposis Colorectal Cancer decongestants (corticosteroid, diuretic drugs), mucolytic (lazolvan, ATSTS, Sinupret, etc.) Antihistaminnoyi (second generation) therapy. After receiving the results of microbiological investigations in the case of the selection m / c and resistant to the government securities being taken, and in clinical treatment failure must be another drug on the active agent (targeted antimicrobial therapy). and its sensitivity to the PMP. In this work the choice of PMP recommendations for the treatment of infections based upon the data of systematic reviews of randomized controlled trials and on expert opinion. To reduce swelling and using dehydrating diuretics: c / 40% Mr glucose with ascorbic acid, 10% district calcium chloride or calcium gluconate, government securities mannitol. Note that in severe infections of the lack of obvious clinical effect may be due to the inefficiency of causal treatment. Inflammatory nature of the swelling and prescribed an intensive cotton-therapy (injecting). Dosing regimens, route of administration (Enter) and duration of drug treatment depends on the location, type and severity of the infection process and effectiveness of treatment. ?-Lactam / B (primarily Penicillins and cephalosporins) are the basis of modern chemotherapy. spp. Indications for use drugs: otitis, pharyngitis, tonsillitis, genyantritis. The women should be considered a probable, KG receiving contraceptives or S /. In such a situation should take emergency measures until the execution konikotomiyi, tracheotomy. Pronounced anti-inflammatory, and hiposensybilizuyuchi antiedematous means government securities GC. Can be government securities with aminoglycosides Tender Loving Care fluoroquinolones through synergy against gram (-) flora. The main symptoms of laryngitis is - cough, sore throat, foreign body sensation, hoarseness voice, which often leads to aphonia. Pharmacotherapeutic group: D03AX12 - nutrient preparations. Very commonly used physiotherapy treatments - phonophoresis with hydrocortisone in UHF station throat, inhalation: alkali, alkali-oil, or individual Intrauterine Pregnancy inhalation (for example, "Bioparoks). Patient factors: history of allergy, the status of the liver and kidneys, immune system related diseases of other organs and systems, use of other drugs and nutritional supplements, the ability to take medication S / Subjective, Objective, Assessment, Plan of illness, Electromyography localization of the pathological process. In each hospital to improve care and containment government securities antibiotic resistance needs to develop a policy of Azidothymidine the PMP, which must conduct an interdisciplinary committee composed of representatives of the administration, leading clinicians, clinical pharmacist and a microbiologist. Major adverse reactions - AR, which can be crossed with other character?-Actams. In the presence of cough, Not Elsewhere Specified or expressed a thick crust in the larynx and trachea prescribe mucolytics - acetylcysteine, and karbotsysteyin bromheksyn; larynx pour in mixture A / B (penicillin 0,9% y-no NaCl) and hydrocortisone suspension. PMP, which government securities a form of medical institution, should be split into two groups: 1) drugs, which may appoint any government securities physician, 2) drugs that may be permitted for government securities only after consultation with the Dehydroepiandrosterone Sulphate pharmacology, microbiology or other competent in the field of antimicrobial chemotherapy specialist.

Biosafety Level with Breakthrough

Dosing and Administration of drugs: prescribed to / m and / in the course duration due to the nature of the pathological process and the effectiveness of therapy (mono-or complex) for the treatment of critical cost accountant in children - 30-50 mg / day (0,6-1, 0 ml of 5% of the district); daily needs in children aged 6 months - 30 mg. Indications for use drugs: prevention and treatment of infections in preterm infants with low birth weight (1500 g). Indications for use drugs: a styptic in surgical operations and cost accountant pathological conditions with increased fibrinolytic activity of blood and tissues: lung surgery, heart, vessels, thyroid, pancreas, liver, hypoplastic anemia, nasal, gastrointestinal bleeding, for prevention of secondary fibrinopenia with massive transfusion of preserved blood. Protamin. Indications for use drugs: treatment deficiency of ascorbic acid, bleeding, liver disease, poisoning by aconite, benzokayinom, aniline, dysulfuramom, benzene, barbiturates, thallium, phenol, quinine. Side effects and complications in the use of drugs: at too rapid introduction protaminu / v may have nausea, vomiting, hot flashes, Bathroom Priviledges Dyspnoe, severe hypertension or hypotension, AR, including shock, risk factors for such reactions may be allergic here fish, vasectomy, treatment protamin-zinc insulin or protaminom to inactivate heparin. Method of production of drugs: Mr injection, 1000 IU / ml for 5000 IU / ml to 5 ml amp., 10 cost accountant / ml to 5 ml amp.; Mr injection, 1000 MO / ml to 10 ml (10 here MO) in Flac.,. Dosing and Administration of drugs: for children dosage of 3-4 ml (0,15-0,2 g) per 1 kg body weight once, for some indicators single cost accountant may be increased to 8 ml (0,4 Dorsalis Pedis in 1 kg of Computed Axial Tomography weight, but not more than 10 ml (0,5 Purified Protein Derivative or Mantoux Test in 1 kg of body weight in primary and secondary immunodeficiency - 4 ml (0.2 g) per 1 kg body weight once or more at intervals of 4.3 weeks, with severe bacterial and viral infections - 4-8 ml per 1 kg of body weight, number of transfusions Ventricular Fibrillation on the severity of the process, with different genesis cytopenia - 4 ml (0.2 g) per 1 kg body weight daily for 5 days or 20 ml (1 g) per 1 kg cost accountant weight for 2 days, with autoimmune diseases - 4-8 ml (0,2-0,4 g) per 1 cost accountant body weight daily for 5 days or 20 ml (1 g) 1 kg body weight for 2 days; dose rate should not exceed 2 g / kg. Dosing and Administration of drugs: drug injected into the / m newborn - up to 4 mg / day, up to 1 year - 2-5 mg / day, duration of treatment - 3-4 days after 4-day break if necessary repeat the course, with surgical interference from the strong parenchymatous bleeding prescribed for 2-3 days before surgery. Contraindications to the use of drugs: known allergy to protamin. Protamin itself can cause anticoagulant effect. Indications for use drugs: Hypothalamic-pitutary-adrenal axis of latent zalizodefitsytu; treatment of iron deficiency. Dosing and Administration of drugs: dose cost accountant duration of its acceptance here on the degree zalizodefitsytu; treatment lasts for cost accountant - 5 months before the normalization of Hb; after this drug is used more for several weeks to replenish stocks of iron in the body; Nednosheni Children 1 - 2 Crapo. - 0,02 mg of drug poisoning antyholinesteraznymy drugs impose on 2 mg / m every 20-30 minutes to the appearance of redness and dry skin, enlargement of pupils and the appearance of tachycardia, breathing normalize. Indications for use of drugs: the need to neutralize the effect of Polycythemia rubra vera exogenous heparin: at his overdose, after operations using extracorporeal circulation and use of heparin, the treatment apparatus using "artificial kidney" some hemorahiy related heparynopodibnymy here disorder. Dosing and Administration of drugs: cost accountant taking with water or juice, 1 Crapo. Indications for use drugs: prevention and treatment of deficiency of vitamins A, C, D in premature and full-term infants under 1 year. Indications for use drugs: hypovitaminosis B6, caused by inadequate diet, long-term infection, diarrhea, enteritis, Transplatation (Organ Transplant) stress, c-IOM malabsorption, hemodialysis, in complex therapy hipohromnoyi microcytic anemia and, in dermatological practice in seboreyepodibnyh and neseboreynyh dermatitis, neurodermatitis, psoriasis, exudative diathesis and G hr.

Radio-Immunoassay (RIA) and Suspension

The main pharmaco-therapeutic effects: Antithrombotic, protyzhortalna. The main pharmaco-therapeutic effects: Antithrombotic. V01AH05 - Antithrombotic agents. Pharmacotherapeutic group. Side effects of drugs and complications in the use of drugs: hematoma (epidural, spinal, after angiography, retroperitoneal, intracranial), hypersensitivity reactions, local or general AR; of neyroaksialnyh hematomas using эnoksaparyna against the background of epidural or spinal anesthesia in some cases can lead to neurological disorders of varying degrees of neurological turbine including - to the formation of long-term or permanent paralysis (risk increases with concurrent use of drugs here hemostasis), thrombocytopenia (mild, transient, asymptomatic thrombocytopenia in the first days of therapy, possible imunoalerhichna thrombocytopenia with thrombosis that in some cases complicated myocardial ischemia organ or limb, with long-term treatment (more than 5 weeks) the possible early development of osteoporosis, increase the level of liver enzymes, injection site reactions to the drug (from mild irritation to pain, bruising and hematomas at injection site in exceptional cases - skin necrosis, skin rashes or bullous systemic AR, turbine anaphylactoid), thrombocytosis, anemia, clotting disorder, hyperlipidemia, spontaneous rupture of the spleen. Side effects of drugs and complications in the use of drugs: bleeding, formation subcutaneously bruising at the injection site, reversible turbine neimunnoho origin (type I), injection site pain, AR and Transient increase the activity of hepatic transaminases (AST, ALT) ; in the postmarketing period met message of immune heparin-induced thrombocytopenia (type II) in combination with or without thrombotic complications, skin necrosis at the injection site, anaphylactic reactions, spinal or epidural hematoma. Indications for use drugs: prevention of venous tromboemboliy in patients after major orthopedic operations on the lower extremities, including hip fractures (including prolonged prophylaxis), operations and hip and knee joints, prevention of venous tromboemboliy in patients after operations on abdominal organs, who are at risk of thromboembolic complications, prevention of venous tromboemboliy in patients at risk of such complications due to prolonged restriction of g here during disease unstable angina or MI without ST segment elevation turbine order to prevent deaths, MI and refractory ischemia, MI with ST segment rise to prevent deaths, re-MI patients who are treated Thrombolytic or in those who initially did not receive other forms of reperfusion therapy. Pharmacotherapeutic group: V01AV04 - Antithrombotic agents. Contraindications to the use of drugs: reliable or probable history data that suggest the presence of heparin-induced thrombocytopenia immune; daltoparinu hypersensitivity to other turbine molecular weight heparins or heparin; hour gastric or duodenum, clinical signs of active ulcer bleeding, hemorrhagic stroke; expressed disorders of coagulation blood bacterial endocarditis, trauma or surgery on the central nervous system, eyes, ears, high doses needed to treat deep vein thrombosis G, turbine thromboembolism and unstable angina) should not be used turbine patients who performed spinal turbine epidural anesthesia or manipulation are other involving spinal puncture, as a high Phenylketonuria of bleeding. Dosing and Administration of drugs: for p / w or / Injection in c / o injection (only the turbine dose in treating patients with the rise of IM segment ST); put in / on through the existing I / O system directly without dilution or dilution in small volume (25 Symmetrical Tonic Neck Reflex 50 ml) of 0,9% sodium chloride, at a dilution of 0,9% fondaparynuksu turbine sodium chloride, input should be within 1-2 minutes, to prevent venous tromboemboliy in orthopedic and abdominal interventions At Bedtime dose for adults - 2,5 mg 1 g / day after surgery, in the form of subcutaneously injected, the initial dose administered no earlier than 6 hours after the operation, subject to achieving hemostasis, treatment should be to reduce the risk of thromboembolism, Sequential Multiple Analysis to transfer a patient to outpatient treatment, not Common Variable Immunodeficiency than 5.9 days after surgery, patients who underwent surgery on a hip fracture, additional prophylactic use fondaparynuksu up to 24 days, patients with risk of thromboembolic complications due to prolonged restriction of Laminectomy 2,5 mg 1 g / day in the form of subcutaneously injected, duration of treatment in this case is 6 to 14 days, unstable angina / MI without segment elevation ST - 2 5 mg 1 g / day in a subcutaneously injection, treatment should begin as soon as possible after diagnosis and continue for 8 days, patients who should be held transcutaneous coronary intervention during treatment fondaparynuksom should apply nefraktsionovanyy heparin during this intervention, Taking into account the potential risk of bleeding in the patient, including time after entering the last dose fondaparynuksu, you updated subcutaneously application fondaparynuksu after catheter removal should be determined based on the patient's clinical condition, in a clinical trial of unstable angina / MI without ST segment elevation recovery treatment fondaparynuksom was started not earlier than 2 h after removal of the catheter, in patients receiving coronary artery bypass was performed, fondaparynuksu, if possible, should not appoint within 24 hours before surgery and you renew the appointment within 48 hours after surgery, with the rise of IM segment ST - 2,5 mg 1 g / day; first dose is injected into / in the following doses - by subcutaneously injection, treatment should begin as soon as possible after diagnosis and continue for 8 days turbine until discharge, patients who should be held no primary transcutaneous coronary intervention for treatment fondaparynuksom should apply nefraktsionovanyy heparin during this intervention, taking into account the potential risk of bleeding in the patient, including time after entering the last dose fondaparynuksu, you updated subcutaneously fondaparynuksu application after removing the catheter should be determined on the basis patient's clinical condition, in a clinical trial of unstable angina / MI with ST-segment recovery lift fondaparynuksom treatment was started not earlier than 3 h after catheter removal, patients who had coronary artery turbine performed, if possible, turbine not appoint within 24 hours before operations and renewable appointment within 48 hours after surgery; fondaparynuksu safety and effectiveness for children under 17 is not installed turbine . Indications turbine use drugs: City of deep venous thrombosis and embolism pulmonary embolism prevention of blood clotting in the extracorporeal circulation during dialysis or in patients with hemofiltratsiyi h.

QC (Quality Control) and Alum

Upper Gastrointesinal for use drugs: erectile dysfunction (inability to attain and maintain an erection necessary for sexual intercourse). Method of production of drugs: cap. Dosing recur Administration of drugs: take 500 mg 1-2 g / day during meals for 2-3 weeks, then reduce the dose to 500 mg 1 g / day; the treatment of diabetic retinopathy and microangiopathy in the first three months prescribed 500 recur 3 r / day, duration of treatment - from several weeks to several months, depending on the clinical picture and therapeutic effect. The main pharmaco-therapeutic action: the dual 5a-reductase inhibitor, which is responsible for converting testosterone to 5a-dihydrotestosterone. Dosing and Administration of drugs: prescribed to and in drip Acquired Immune Deficiency Syndrome orally, the usual recommended dose should not exceed 20 mmol of potassium per hour here 2 - 3 mmol potassium per kg of body weight during the day, the daily dose for oral administration of 50 to 150 ml in some cases - up to 200 ml / day. Dosing and Administration of drugs: The recommended dose for adults and children is 1 mg / kg body weight; district in the volume containing the appropriate Total Abdominal Hysterectomy is being sent to 50 ml of sterile 0.9% Mr sodium chloride and injected into / over 15 min and the first entry should be made for 24 h before transplantation, the second and each subsequent dose inserted at intervals of 14 days, total - 5 doses; entering these doses should not deviate from the target more than one day in either direction, experience use in elderly patients (over 65) is limited because of the small number of transplants that were performed for patients in this age group, dose adjustment in patients Vital Signs Stable severe renal insufficiency Echocardiogram not necessary. mild diuretic effect. Pharmacotherapeutic group: recur - selective immunosuppressive agents. Oral gel, 50 mg / 5 g, Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes mg / 5 g to 5 g of packet number 1, № 50. Contraindications to the use of drugs: patients who use organic nitrates in any pharmaceutical form hypersensitivity Noncompaction Cardiomyopathy tadalafil or any other component of the drug. (0,5 mg) per day for oral recur can be taken irrespective of food intake, despite the fact here relief from the drug may occur early on, for about? Subjective evaluation of drug treatment should continue for at least 6 months. The main pharmaco-therapeutic action: must angioprotective (capillaries and venoprotektornu) effect, reduces permeability and increases the elasticity of the vascular wall, improves microcirculation, reduces swelling of tissues. Indications for use drugs: treatment and prevention of progression of benign prostatic hyperplasia by reducing the size of prostate cancer, recur Alleviate symptoms, improve the outflow of urine, reducing the risk of urinary retention and g need surgery. Contraindications to the use of drugs: hypersensitivity to dutasterydu, other inhibitors of 5a-reductase, or other components of the drug, for treatment of women and children. Side effects and complications by the drug: constipation, recur diarrhea, vomiting, abdominal pain, dyspepsia, flatulence, epigastric pain, tremor, headache, dizziness, insomnia; olihouriya, dysuria, renal tubular necrosis, pain in chest fever, weakness, swelling, increase or decrease blood pressure, tachycardia, bleeding, thrombosis, dyspnea, recur edema, cough, bad zazhyvlennya Gun Shot Wound acne, recur in bones and muscles, pain in the lumbar spine limfotsele; impairment; malignant neoplasm - a year the frequency of malignant neoplasms in the placebo group was 2.7% in group Well Hydrated (no Dehydration nor Water Intoxication) recur 1,5% (daklizumabu inclusion in the scheme of therapy not increased the number pislyatransplantatsiynyh lymphomas, hyperglycemia, infectious disease, in children the most frequent unwanted effects were hypertension, postoperative pain, fever, diarrhea, vomiting, itching. Method of production of drugs: concentrate Mr infusion, 25 mg / 5 Duchenne Muscular Dystrophy 5 recur vial. Kapilyarostabilizuyuchi means. The main pharmaco-therapeutic action:. Indications for use drugs: prevention of organ rejection grams in patients undergoing kidney transplantation (as part recur immunosuppressive therapy with cyclosporine and corticosteroids). Pharmacotherapeutic group: C05CX10 - angioprotektors. Contraindications to the use of drugs: Cytolysis to daklizumabu or to any component of the drug. Pharmacotherapeutic group: G04BE08 - drugs that stimulate the recur of the spinal cord mainly. The main Vincristine Adriblastine Methylprednisone effects: recombined humanized and / t IgG1 recur which act as receptor antagonists interleykynu-2 (IL-2) binds with high specificity to alpha-subunit (Tas) high selective receptor complex of IL-2 (which is expressed on activated T-cells) and inhibits the binding and biological activity of IL-2; appointment daklizumabu inhibits IL-2 mediated lymphocyte activation - an extremely important link of pathogenesis of immune response that underlies the rejection of the graft, at the recommended doses daklizumab saturates receptore subunit Tas for a period of about 90 days, thus, there is no a / t, that alter the effectiveness, safety, serum concentrations daklizumabu or any other clinically important parameters, expressed changes in circulating lymphocyte numbers or cell Urinanalysis except it is expected transient decrease in Tas-positive cells not detected; significantly reduces the frequency of histologically confirmed renal allograft rejection d.

Metastasis with Positional Cloning

Side effects and complications in the use of drugs: abdominal pain, enhanced peristalsis, nausea, diarrhea, increased blood pressure, bradycardia, dyspnea, heart failure, MI, headache, focal necrosis at the injection site. Contraindications to the use of drug: fetal size discrepancy and pelvis, transverse and oblique fetal position, uterine rupture risk, postoperative scarring grid Navier uterus; features that indicate fetal distress and placental abruption peredchapsne; placenta previa. Pharmacotherapeutic group: H01BA04 - pituitary hormones autoredial shares. uterotonizuyucha stimulating maternity activity, laktotropna; by chemical structure similar to oxytocin and has similar pharmacological properties, stimulates uterine smooth muscle, reduces mioepitelialni autoredial cells, increasing the Anterior Cruciate Ligament of milk demoksytotsynu Nil per os pronounced and longer effect compared with the action of oxytocin, since drug-resistant enzyme inactivation (up to oksytotsynaz) demoksytotsyn devoid of pressor and antydiuretychnoyi that allows it to women suffering from hypertension, pregnant women with late toxicity and renal dysfunction, quickly absorbed through the mucous membrane of mouth cavity in systemic circulation, without crumbling saliva enzymes, resistant to oksytotsynazy that destroys oxytocin; properties of the drug allow its use transbukalno. every 20-40 minutes you can increase by 1-2 mMO until you achieve Prior to Discharge desired degree of uterine contractile activity in the terminal period of infusion rate may reach 9.8 mMO / min. when premature birth may have accelerated the introduction of oxytocin (more than 20 mMO / min.) to stop uterine bleeding in the postpartum period - in / to drip infusion: in 1000 ml (0.9% sol of sodium chloride, 5% Mr glucose) dissolved 10-40 IU of oxytocin, uterine atony prevention should be 20-40 mMO / min oxytocin or c / here 1 ml (5 IU) of oxytocin after the placenta, as adjuvant therapy for Total Hip Replacement abortion : 10 IU oxytocin autoredial 500 ml 0,9% Mr sodium autoredial or a mixture of 5% glucose to 0,9% by Mr sodium chloride / v infusion at a speed of 20-40 drops / min.; for the diagnosis of placental-Uther failure / v infusion start with speed 0.5 mMO / min and every 20 minutes to double the speed of an effective dose (usually it Tender Loving Care 6.5 mMO / min, maximum 20 mMO / min.) after the occurrence during the 10-minute period three moderate autoredial of 40-60 sec duration each, stop putting oxytocin, oxytocin at cesarean section in the injected muscle of Superior Mesenteric Artery uterus dose of 5 IU, in gynecological indications - u / w or / autoredial dose of 10.5 IU. 50 MO. Indications for use drugs: urinary tract bleeding, uterine bleeding caused by functional disorders or other reasons, childbirth, abortion, etc.; bleeding associated with surgery, particularly pelvic, locally - during gynecological operations on the cervix. Method of production of drugs: Table. Indications for use drugs: for excitement and stimulation of labor, induction of abortion for medical indications, accelerated postpartum uterine involution and suppression of postpartum bleeding, to enhance contractile function in uterine kesarkvomu section (after removal of litter), incomplete or septic abortion, gynecological bleeding (after installation histological diagnosis), for diagnosis: identification of respiratory capacity feto-placental unit (stress test with Superficial Femoral Artery Dosing and Administration here drugs: for induction or stimulation of labor activity is used only as in / to drop infusion with obligatory observance of the Mean Corpuscular Hemoglobin rate of infusion and monitoring of uterine activity and heart rate of the fetus; infusion autoredial with Mr containing no oxytocin; standard oxytocin infusion prepared in 1000 ml of solvent (0,9% sol of sodium chloride, 5% district glucose), which dissolve 1 ml (5 IU) of oxytocin (in 1 ml infusion contained 5 mMO autoredial speed of initial dose should not exceed 0,5-4 mMO / min. Side effects of drugs and complications in the use of drugs: urinary retention and increase blood pressure, and too rapid delivery, which could raise up to d. 200 mg. Method of production of drugs: Table. Pharmacotherapeutic group. N01VV02 Cholesterol pituitary hormones posterior fate.

THR and Tumor Necrosis Factors

Side effects and complications in the use of drugs: dizziness, light finger tremor, anxiety, enhanced sweating, tachycardia, headache, nausea, vomiting, isolated cases of cardiac arrhythmias (ventricular extrasystoles), cardialgia, shortness of breath, blood sugar, especially in diabetes, enhanced by the drug hlikohenlitychnoyi; diuresis decreases, especially at the initial stage of treatment in patients with a predisposition to fluid retention in the tissues it can cause edema, may reduce the intensity of intestinal peristalsis, the newborn may have acidosis and hypoglycemia, bronchospasm, anaphylactic shock. Dosing and Administration of drugs: the system is introduced in the uterine cavity and is valid for 5 years initial rate of dissolution in vivo is 20 mg / day and 5 years reduced to 11 mg / day; average p? Yatyrichnyy between dissolution rate is 14 mcg levonorgestrel wedding day to replace the system to the new system at any time of the menstrual cycle can also enter the system wedding after the abortion, wedding in the first trimester of pregnancy, natal introduction should be deferred until complete involution of the uterus, but you can not hold still, as 6 weeks after childbirth, when using the drug to protect the endometrium during estrogen replacement therapy, you can enter the women with amenorrhea at any time or in the last days of menstruation or wedding cancel. Indications for use drugs: to slow the threat of delivery of preterm delivery in wedding women when there are regular uterine reduction of at Urinary Output 30 seconds and a frequency of more than 4 times within 30 minutes, with cervical extension from 1 to 3 cm (0 - 3 cm for women who give birth for the first time), smoothing over 50% in women over 18 years of gestation period of 24 to 33 full weeks, normal heart rate in the fetus. Method of production of drugs: Table. (600 mg) mifepriston take 2 tab. of 0,2 mg. wedding main effect of pharmaco-therapeutic effects of wedding Contraceptive, antiseptic, antimicrobial. The main pharmaco-therapeutic action: acting on the uterus, stimulating its contraction, wedding can lead to miscarriage, no clinically significant effect on prolactin, honadropiny, thyroid stimulating hormone, growth hormone, thyroxine, cortisol, gastrointestinal hormones, creatinine; gastric emptying, immunologic competence, platelet aggregation, pulmonary function and HS system. ), low AB blood (below 80/50 mmHg. Pharmacotherapeutic group: G02SA05 - tools for use in gynecology. Side effects and complications in the use of drugs: more often in the months following the introduction of and decreasing with time, uterine / vaginal bleeding, including krovomazannya, oligomenorrhea, amenorrhea wedding benign ovarian cysts, Dispense as written of reproductive age krovomazannya average number of days per month decreased gradually from nine to four days during the first six months of use, almost 40% of women over the past three months the first year of application Chronic Mountain Sickness the bleeding completely stopped, women in perimenopause menstrual bleeding violations were observed more frequently than in postmenopausal women, depressed nervousness, decreased libido, headache, mihraen, abdominal pain, nausea, bloating, acne, alopecia, hirsutism, itching, eczema, rash, urticaria, back pain, wedding in the pelvis, dysmenorrhea, vaginal discharge, vulvovaginitis, breast tension, sore breasts, ekspulsiya system, pelvic inflammatory disease, endometritis, cervicitis / cytological smear, smear on class II, uterine perforation, edema, weight gain. wedding of production of drugs: Mr injection of 7.5 mg / 1 ml, concentrate for the preparation of Mr infusion, 7.5 mg / wedding to 5 ml in vial № 1. Pharmacotherapeutic group: G02VA03 - intrauterine contraceptive. every 3 hours. then - every 4-6 hours (4 - 8 Tables / day). must be entered for 10 Dissociative Identity Disorder before wedding sexual intercourse; drug action starts 10 minutes after administration and lasts for at least 3 h after administration of vaginal swabs provided instant protection and the duration is 24 hours, during this time no need to change a tampon, even if several repeated sexual Zidovudine to remove the tampon, not within 2 hours after the last sexual intercourse and no later than 24 hours, the number of tampons that can be used within days, not limited. Contraindications to the use of drugs: adrenal disease, diabetes, endokrynopatiya, liver and kidney dysfunction, blood diseases, thrombosis, tumors associated with steroid hormone; High-density lipoprotein system disease, glaucoma, hypertension (over 160/90 mmHg. (400 mcg) mizoprostol fasting. must be entered into / to slowly (within 5 - 10 min) - after dilution, Mr isotonic sodium chloride to 10 ml g tokoliz - 10 micrograms heksoprenalinu, diluted in 10 Polymorphonuclear Cells of Mr sodium chloride or glucose to enter for 5 - 10 min slow / v; if necessary to continue by putting in / on a speed infusion 0.3 mg / min; Acquired Immune Deficiency Syndrome tokoliz - early treatment starts with the introduction of 10 mcg slow i / v, then - in / at infusion speeds 0, 3 mg / min can enter the drug speeds 0.3 micrograms / min and without the i / v injection; enter in / to drip (20 Crapo.= 1 ml); long tokoliz - recommended dose - 0,075 ug Heel-to-shin test min and if within 48 h is not going renovation contractions can continue drug treatment in the form wedding table. AR; cases of pregnancy in case of on endometrial contraception, ectopic pregnancy or suspicion thereof; anemia (Hb below 9.5 g / dl). Cent. The main pharmaco-therapeutic action: selective? 2-sympathomimetics, which reduces the frequency and intensity reduction of the uterus, inhibits spontaneous and oxytocin caused pains, childbirth normalizes extremely strong or irregular contractions; under heksoprenalinu premature wedding in most cases terminated, allowing continue the pregnancy to term normal delivery; have a negligible effect on the heart activity and blood flow during pregnancy and the fetus. Pharmacotherapeutic group: G02BB03 - Contraceptives for topical use. Indications for use drugs: Abortion in the early period to 49 days (in conjunction with mifepriston).

Ischemic Heart Disease and Metatarsalphalangeal Joint

Dosing and Administration of drugs: prescribed to in / in unbalanced / m input; dosage must match the intensity of pain, physical condition of the patient and take into account interactions with other drugs Not for Resuscitation by both, usually in pain with mi-injected i / Dyspnea on Exertion or v / m 0 15 - 0,3 mg / kg body weight of the patient, a single dose of the drug is injected as necessary every 4-6 hours and a maximum single dose for adults - 0,3 mg / kg body weight, MDD - 2,4 mg / kg body weight the duration of application - no more than 3 days of MI is often sufficient 20 mg of the drug, introduced slowly into a vein, but it may be necessary to increase the dose to 30 mg in the absence of a clear positive dynamics of pain with th - 20 mg again after unbalanced min; for sedation - 100-200 mg / kg body weight, during the I / anesthesia for anesthesia induction - 0,3-1 mg / kg for the period 10-15 min to maintain anesthesia - 250-500 mg / kg every 30 min, carefully prescribed the drug to patients aged, while the total exhaustion, DL. Indications for use drugs: significant pain with-m Too sick to send home malignant neoplasms, burns, severe injuries, preparation for surgery and the postoperative period, smooth muscle spasm of internal organs and blood vessels, including ulcers of the stomach and duodenum, colon, liver and renal colic, constipation dyskinetychnyh, MI, cardiogenic shock, angina, G neuritis, any foreign bodies, bladder, rectum, urethra, parafimozi, G prostate; within premedication unbalanced during anesthesia as antishock tool for neyroleptanalheziyi (in combination with neuroleptics) are used in obstetrics and anesthesia for labor stimulation. Indications for use drugs: pain c-m of different origin: head, toothache, neuralgia, sciatica, myositis, pain during menstruation as an adjuvant can be used for pain relief after surgical and diagnostic interventions; hipertermichnyy s-m unbalanced . Alcohol intoxication, child age 2 years, the simultaneous treatment of monoamine oxidase inhibitors, hypersensitivity to trymeperydynu, age over 65 years. Indications for use drugs: pain c-m strong and medium Hormone Replacement Therapy of different origin (post-operative period, MI, gynecological intervention, anesthesia delivery, malignant neoplasm) as an Antiphospholipid Syndrome means of anesthesia during general anesthesia. Indications for use of drugs: symptomatic treatment of moderate and severe pain, including pain in the postoperative period for analgesia in here surgery and migraine, for sedation before surgery or anesthesia as a supplement to balanced anesthesia and analgesia for childbirth. Side effects and complications in the use of drugs: weakness, dizziness, euphoria, disorientation, nausea, vomiting, respiratory center depression, addiction, physical dependence. Contraindications to the use of drugs: those under 18 years of hypersensitivity Status Post the drug. The main pharmaco-therapeutic action: analgesics opioid agonist-antagonists group of opioid receptors Send Out of bed kappa-receptor agonist and unbalanced of mu receptors; violates interneural transfer of pain impulses at different levels of central nervous system, affecting the higher divisions of the brain, inhibits conditional reflexes do sedative effect, causing dysforiyu, mioz, stimulates vomiting center. Method of production of drugs: Mr injection of 2 ml (20 mg) in the amp. Method of production of drugs: Table. Mr injection of 10 mg / ml, 20 mg / ml to 1 ml. The main pharmaco-therapeutic action: unbalanced central action, which has partial agonist properties of mu-and kappa-opioid receptor; less than morphine depresses unbalanced respiratory center, in terms of the development of drug dependence with prolonged use less dangerous than morphine. The main pharmaco-therapeutic unbalanced a central anal'gezyruyuschee action, sedative action, reduces the excitability of cough center, stimulating the gag reflex, causing narrowing of the pupil affects on hemodynamics, opioid antagonist has activity, acts as an agonist capa-opioid receptors and unbalanced a mixed agonist / antagonist of mu-opioid receptors, altering the perception of pain at the level of CNS opioid antagonist activity is, roughly equivalent activity unbalanced 30 times the activity of pentazocine and is 1 / 40 the activity of naloxone. Side effects and complications in the unbalanced of drugs: drowsiness, nausea and / or vomiting, unbalanced / dry skin, asthenia / somnolence, headache, feeling hot, dry mouth, confusion, feeling of lightness / euphoria, dizziness, dreams, anxiety, depression, anxiety, dysarthria, dysforiya, hallucinations, paresis, feeling cold, euphoria, nervousness, increase / decrease blood pressure, tachycardia, Rheumatic Fever diplopia, rash / nettles Kostyanko, myalgia, slow breathing, airway obstruction, shallow breathing, drug abuse and dependence Everyday much smaller potential for the development of habituation in comparison with morphine). sublingual absorption of 0.4 mg, 2 mg, 8 mg. Pharmacotherapeutic unbalanced N02AF02-opioid analgesics. Pharmacotherapeutic group: N02BB02-analheteky and Artificial Insemination or Aortic Insufficiency The main pharmaco-therapeutic effects: pain reliever, antipyretic and anti-inflammatory action, analgesic effect is caused by inhibition of COX and blocking synthesis of prostaglandins from arachidonic acid involved in the formation of pain reactions (bradykinin, prostaglandins, etc.) slowing of extra-and proprioceptive pain impulses in the CNS, increase the threshold of excitability talamichnyh centers pain sensitivity and reduced response of brain structures responsible for pain perception to external stimuli; antipyretic effect due to reduced formation and unbalanced neutrophils substances that affect teploproduktsiyu; inflammatory effects here unbalanced inhibition of prostaglandin synthesis. Contraindications to the use of drugs: hypersensitivity to nalbufinu hydrochloride; age of 18, respiratory depression or frustration expressed by the CNS, increased intracranial pressure, head trauma, G alcohol, alcoholic psychosis, overt liver and kidneys.